Hi Jonathan! I run a newsletter that is hyper-focused on the crowdfunding industry and goes out to nearly 5,000 retail investors each week. I'm interested by your raise - my grandfather has dealt with skin cancer complications in the past decade. I would love to chat for a pot...

Hi Kevin, we just reached out to you via email! Thanks for reaching out.

Hi, Can you tell us a bit about your IP portfolio? Thanks. Blessings

Hi! Happy to share more information about our IP portfolio: - we have an exclusive license for 2 issued patents for subdermal imaging from the Stevens Institute - we have one patent pending on full-body dermoscopy - we are preparing 3 more patents related to the patient flow, the design of the machine and our AI model Feel free to ask more questions, I would be happy yo answer.

Hi! Skinbit sounds like it is solving a problem that impacts a large population. I would like to invest and this is an exciting opportunity! I looked through the information provided on Wefunder, but I could not find information on the price per share valuation. What is the pr...

Thank you so much for your interest in SkinBit! We're thrilled that you see the potential in what we're building to address this critical healthcare need. I'd be happy to clarify our current funding structure. We're raising capital through a SAFE (Simple Agreement for Future Equity) with a $15M post-money valuation cap, rather than selling traditional shares at a fixed price per share. How SAFE Conversion Works: Your SAFE will convert to actual shares when we raise our next priced equity roun...

Hello, I’ve had a melanoma removed and am concerned about the 5 minute whole body exam being thorough enough. This sounds like a big improvement in the screening process. In response to the Dr.’s comment about this being competition rather than a tool for him, does the Dr./fac...

Dear Denise, thank you for your question. We tried to contact dr Wylde without success. SkinBit is designed to generate revenue for doctors, especially primary care physicians, who will now be able to offer a full-body screening with the performance of an expert dermatologist. Our objective is to make sure our platform can be deployed at any point of care, including primary care practices. As for our IPO, it is our objective, but we can't comment on when this would happen.

Hello, Thank you so much for addressing this important matter. This sounds like amazing innovation that can contribute to a better patient experience, increased potential for improved outcomes as a result of opportunities for earlier diagnosis, and something that will ultimate...

Hi W&M L! Thank you for your message! Let me address your questions below: 1. The scan will only capture what is visible to the scanner. In our initial version, the system will use dermoscopic imaging, so it won't be able to see inside folds. We address this by doing a double pass: one with the arms along the body and another with the arms raised above the head. This helps stretch the areas with folds. In our second version, we will be able to image through hair using our subdermal imagin...

SkinBit

Early Skin Cancer detection for everyone

skinbit.co

Los Angeles, CA

Technology Notable Angel B2B Healthcare SaaS

Highlights

Notable Angel

Raised $25k or more from a notable angel investor

Repeat Founder

Started a prior company with $2M+ in funding or revenue

Repeat founders: CEO: 3 exits including Deezer ($1B+ IPO), Stanford Chief of Dermatology, Apple/Meta

$15B market: 98M Americans need annual skin screening, versus only 48M capacity today

Team

Overview

SkinBit

Quick facts

Team profiles

$2,166,321

Highlights

Related company links

Team